# Materialise Share-Buy Back Program
Canonical URL: https://biopharmsignal.com/news/MTLS/materialise-share-buy-back-program
Ticker: MTLS
Company: Materialise
Source: Materialise
Published: 2026-04-20 20:00 EST
Original Source URL: https://investors.materialise.com
## Summary

Leuven – 20 April 2026 – 22h00 CET                                     Regulated information 1 Materialise reports on the progress of its sh

## Article Body
Leuven – 20 April 2026 – 22h00 CET                                     Regulated information 1 Materialise reports on the progress of its share buy-back program announced on 30 October 2025. 20 April 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS) (“Materialise”) (“the Company”) hereby
## Recent Company News
- 2026-05-16 02:00 EST — [Materialise houdt jaarlijkse aandeelhoudersvergadering op 16 juni 2026](https://biopharmsignal.com/news/MTLS/materialise-houdt-jaarlijkse-aandeelhoudersvergadering-op-16-juni-2026) — Source: Materialise
- 2026-05-15 20:01 EST — [Materialise to Hold Annual Shareholders’ Meeting on June 16, 2026](https://biopharmsignal.com/news/MTLS/materialise-to-hold-annual-shareholders-meeting-on-june-16-2026) — Source: Materialise
- 2026-05-08 03:13 EST — [Materialise rapporteert resultaten eerste kwartaal 2026](https://biopharmsignal.com/news/MTLS/materialise-rapporteert-resultaten-eerste-kwartaal-2026) — Source: Materialise
- 2026-05-07 05:00 EST — [Materialise Reports First Quarter 2026 Results](https://biopharmsignal.com/news/MTLS/materialise-reports-first-quarter-2026-results) — Source: Materialise
- 2026-04-23 05:00 EST — [Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026](https://biopharmsignal.com/news/MTLS/materialise-nv-to-report-first-quarter-2026-earnings-on-thursday-may-7-2026) — Source: Materialise
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)